You are here

  • Home
  • Archive
  • Volume 69, Issue 9
  • Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia

Article metrics

Article menu
Download PDFPDF
Original article
Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia

 

Online download statistics by month:

Online download statistics by month: January 2016 to March 2024

AbstractFullPdf
Jan 2016186612
Feb 2016138117
Mar 20166811
Apr 20166253
May 20164412
Jun 20163247
Jul 20161711
Aug 20162471028
Sep 2016244217
Oct 2016168511
Nov 201618295
Dec 201610042
Jan 20176839
Feb 20173425
Mar 201729107
Apr 20171755
May 20172423
Jun 20174611
Jul 20174042
Aug 20175534
Sep 20173600
Oct 20174923
Nov 20176822
Dec 20178732
Jan 20188621
Feb 20183710
Mar 20185252
Apr 20184820
May 20186400
Jun 20185611
Jul 20187521
Aug 201810900
Sep 20189131
Oct 20186133
Nov 20187443
Dec 201818000
Jan 20196611
Feb 20195500
Mar 20196534
Apr 20195133
May 20192555
Jun 20191600
Jul 20192930
Aug 20194420
Sep 20193300
Oct 20194311
Nov 20195800
Dec 20192640
Jan 20204642
Feb 20202810
Mar 20204642
Apr 20201621
May 20203100
Jun 20202210
Jul 20202922
Aug 20202241
Sep 20202700
Oct 20204044
Nov 20201800
Dec 20201400
Jan 20211410
Feb 20213401
Mar 20212510
Apr 20217022
May 20211010
Jun 2021221
Aug 2021110
Sep 2021210
Oct 20212400
Nov 20212310
Dec 20214200
Jan 20225100
Feb 20225021
Mar 20224312
Apr 20223000
May 20224621
Jun 20224020
Jul 20223331
Aug 20226642
Sep 20225361
Oct 20229122
Nov 20222711
Dec 20221500
Jan 20232712
Feb 20237020
Mar 20231230
Apr 20231000
May 20231710
Jun 20231610
Jul 20232000
Aug 20231600
Sep 2023622
Oct 20233930
Nov 20233611
Dec 20231210
Jan 20241316
Feb 20243111
Mar 20241422
Total4955215206